bcl2, p53 and bax in thyroid tumors and their relation to apoptosis

被引:1
|
作者
Farid, P [1 ]
Gomba, S
Péter, I
Szende, B
机构
[1] Semmelweis Univ, Inst Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary
[2] Univ Debrecen, Inst Pathol, Debrecen, Hungary
[3] Natl Inst Oncol, Budapest, Hungary
关键词
p53; bax; bcl(2); thyroid tumors;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Twenty five thyroid tumors were investigated by immunohistochemistry for the presence of apoptosis, expression of p53, bax and bcl(2). In nine adenomas (average age 40) the rate of p53 positive cells was 5.7%, while it was 13.3% for bax and 41.7% for bcl(2) in the tumor cells. In six follicular carcinomas (average age 56) p53 positivity was obtained for 71.1%, while bax and bcl(2) positivity constituted 3.4 to and 2.5 to, respectively. In ten papillary adenocarcinomas (average age 42) p53 was positive in 39.6%, but bax and bcl(2) were positive in 3.4% and 3% of the tumor cells, respectively. Almost no signs of spontaneous apoptosis were found in any of the cases. Determination of p53, bax and bcl(2) ratio in thyroid tumors may contribute to the differentiation between follicular adenomas and carcinomas.
引用
收藏
页码:299 / 301
页数:3
相关论文
共 50 条
  • [31] Apoptosis and p53, Bcl-2 and Bax gene expression in parathyroid glands of patients with hyperparathyroidism
    Szende, B
    Farid, P
    Végso, G
    Perner, F
    Kopper, L
    PATHOLOGY & ONCOLOGY RESEARCH, 2004, 10 (02) : 98 - 103
  • [32] MEDIATORS OF INCREASED APOPTOSIS IN STRESSED DIABETIC FIBROBLASTS: P53 CONTROLOF BAX AND BCL-2
    Nguyen, Phuong D.
    Allen, Robert J., Jr.
    Tutela, John Paul
    Thanik, Vishal D.
    Haberman, Ilyse D.
    Valenzuela, Christian
    Lee, Judy Washington
    Levine, Jaimie P.
    Warren, Steve M.
    Saadeh, Pierre B.
    WOUND REPAIR AND REGENERATION, 2009, 17 (02) : A10 - A10
  • [33] CHARACTERIZATION OF A NOVEL PROTEIN WHICH INTERACTS WITH BOTH BCL2 AND P53 - IMPLICATIONS FOR THE REGULATION OF APOPTOSIS
    NAUMOVSKI, L
    CLEARY, ML
    BLOOD, 1994, 84 (10) : A373 - A373
  • [34] Bax, Bcl-2, and p53 expression in endometrial cancer
    Sakuragi, N
    Salah-eldin, A
    Watari, H
    Itoh, T
    Inoue, S
    Moriuchi, T
    Fujimoto, S
    GYNECOLOGIC ONCOLOGY, 2002, 86 (03) : 288 - 296
  • [35] Tumor characteristics, expressions of ERCC1, Bax, p53, IGF1R, Bcl2, Bcl2/Bax and prognostic factors for overall survival in patients with lung carcinoid
    Velinovic, Marta
    Jankovic, Radmila
    Jovanovic, Dragana
    Trifunovic, Vesna Skodric
    Gavrilovic, Dusica
    Stojsic, Jelena
    Cavic, Milena
    JOURNAL OF BUON, 2019, 24 (01): : 256 - 266
  • [36] Amelioration of DMH-induced colon cancer by eupafolin through the reprogramming of apoptosis-associated p53/Bcl2/Bax signaling in rats
    Wang, Congcong
    Qiao, Xiao
    Wang, Jingwen
    Yang, Jia
    Yang, Chen
    Qiao, Yi
    Guan, Yue
    Wen, Aidong
    Jiang, Liuqin
    EUROPEAN JOURNAL OF INFLAMMATION, 2022, 20
  • [37] Amelioration of DMH-induced colon cancer by eupafolin through the reprogramming of apoptosis-associated p53/Bcl2/Bax signaling in rats
    Wang, Congcong
    Qiao, Xiao
    Wang, Jingwen
    Yang, Jia
    Yang, Chen
    Qiao, Yi
    Guan, Yue
    Wen, Aidong
    Jiang, Liuqin
    EUROPEAN JOURNAL OF INFLAMMATION, 2022, 20
  • [38] Prognostic markers for colorectal cancer: Expression of P53 and BCL2
    Pereira, H
    Silva, S
    Juliao, R
    Garcia, P
    Perpetua, F
    WORLD JOURNAL OF SURGERY, 1997, 21 (02) : 210 - 213
  • [39] Prognostic markers for colorectal cancer: Expression of P53 and BCL2
    Hermínia Pereira
    Salete Silva
    Rui Julião
    Palla Garcia
    Fátima Perpétua
    World Journal of Surgery, 1997, 21 : 210 - 213
  • [40] Dysregulated p53, bcl2 and fas expression in keloids.
    Ladin, DA
    Patel, D
    McPhail, M
    Olson, JC
    Fivenson, DP
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (04) : 602 - 602